4-Acetyl-1-methylcyclohexene
Common Name: |
4-Acetyl-1-methylcyclohexene |
IUPAC Name: |
1-(4-methylcyclohex-3-en-1-yl)ethanone |
Molecular Formula: |
C9H14O |
SMILES: |
CC1=CCC(CC1)C(=O)C |
Inchi: |
1S/C9H14O/c1-7-3-5-9(6-4-7)8(2)10/h3,9H,4-6H2,1-2H3 |
Inchi Key: |
HOBBEYSRFFJETF-UHFFFAOYSA-N |
Cas No: |
70286-20-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
138.21 |
Mass (g/mol) |
138.104 |
Molar Refractivity |
42.99 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
189.5 |
Vapor Pressure (mmHg@25.00 °C) |
0.6 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
2.322 |
iLOGP |
2.11 |
XLOGP3 |
1.34 |
WLOGP |
2.32 |
MLOGP |
1.89 |
ESOL Log S |
-1.48 |
ESOL Solubility (mg/ml) |
4.63 |
ESOL Solubility (mol/l) |
0.034 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.30 |
Ali Solubility (mg/ml) |
6.92 |
Ali Solubility (mol/l) |
0.05 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.76 |
Silicos-IT Solubility (mg/ml) |
2.4 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.482 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.741 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |